-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.
-
Summary
-
Supernus Pharmaceuticals, Inc. quarterly/annual Interest Paid, Excluding Capitalized Interest, Operating Activities history and growth rate from Q1 2019 to Q1 2023.
- Supernus Pharmaceuticals, Inc. Interest Paid, Excluding Capitalized Interest, Operating Activities for the quarter ending March 31, 2023 was $0.000, a 100% decline year-over-year.
- Supernus Pharmaceuticals, Inc. annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2022 was $2.52M, unchanged from 2021.
- Supernus Pharmaceuticals, Inc. annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2021 was $2.52M, unchanged from 2020.
- Supernus Pharmaceuticals, Inc. annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2020 was $2.52M, unchanged from 2019.
Interest Paid, Excluding Capitalized Interest, Operating Activities, Quarterly (USD)
Interest Paid, Excluding Capitalized Interest, Operating Activities, YoY Quarterly Growth (%)